Budesonide
(Redirected from Pulmicort)
| Drug monograph · NCLEX study reference | |
| Trade names | Pulmicort |
|---|---|
| Therapeutic class | Anti-inflammatory (respiratory) |
| Pharmacologic class | Inhaled corticosteroid |
| Onset / peak / duration | Builds over days to weeks. |
| Half-life / level | Local action. |
| Routes | Inhaled |
| High-alert (ISMP) | No |
| Black box warning | None |
| Antidote / reversal | Not applicable. |
| Pregnancy / lactation | Often preferred ICS in pregnancy. |
Nursing pharmacology study reference (NCLEX-style monograph). Numeric values are standard teaching ranges for study and must be verified against current manufacturer labeling before clinical use. This is educational content, not prescribing guidance.
Budesonide (brand name Pulmicort) — Anti-inflammatory (respiratory); Inhaled corticosteroid.
Identification
- Therapeutic class: Anti-inflammatory (respiratory).
- Pharmacologic class: Inhaled corticosteroid.
Pharmacology
- Mechanism of action: Reduces airway inflammation; nebulized form common in young children.
- Onset / peak / duration: Builds over days to weeks.
- Half-life / therapeutic level: Local action.
Clinical use
- Indications: Asthma maintenance.
- Usual dose, route, frequency: Inhaled or nebulized one to two times daily.
- Maximum dose / adjustments: Lowest effective dose.
Safety
- Contraindications: Acute bronchospasm primary treatment, hypersensitivity.
- Black box warning: None.
- Interactions: Strong CYP3A4 inhibitors.
- Pregnancy / lactation: Often preferred ICS in pregnancy.
- High-alert: No.
Adverse effects
- Common side effects: Thrush, hoarseness.
- Serious effects to report: Persistent thrush, growth slowing in children.
- Antidote / reversal: Not applicable.
Nursing process
- Assessment before administration: Respiratory status, oral mucosa.
- Interventions during therapy: Rinse mouth after; for nebulized, rinse face to avoid skin irritation.
- Monitor: Symptom control, growth in children.
- Evaluation / expected outcome: Improved control.
Patient teaching
- Patient teaching: Daily controller; rinse mouth after.
- Notify provider if: Worsening symptoms, white mouth patches.
- Administration tips: Rinse after use; wash face after nebulizer.